Generic Hospice

When hospice reverts to the lowest common denominator and leaders obsess about metrics, it's time to speak. Self-inflated leaders assume clinicians give until their backs break, given no raises for years. A clinical ladder is a rainbow’s pot of gold. Others have a sorrier job and must be motivated by money. Abysmal leaders dangle extrinsic rewards for admission, hiring and EDBITA targets. “Sign on” bonuses entice people into a poor work environment. Employees’ voice equals their raise, zero.

Monday, July 21, 2014

Kindred Looks Increasingly Desperate

StrangeTony,

Kindred's CEO Paul Diaz raised the offer for Gentiva to $17.25 per share. A week ago Kindred said $16 but no higher without a date where Kindred gets to look at the goods. Value, like beauty, is in the eye of the beholder.

Kindred's desperate offer matches that of a mysterious white knight, likely a leveraged buyout organization (LBO). Firms mentioned as possible bidders include GTCR, Cressey & Co,, Formation Capital and KKR.

Emergence of the mystery bidder left Kindred with a difficult choice: either walk away from Gentiva and watch a possible competitor buy a company it wanted and outflank it in the healthcare marketplace or swallow hard and raise its bid.

The testosterone meter is dinging like an alarm clock. Kindred punch thrown. And the LBO/White Knight response?

Anonymous (from Gentiva)

2 comments:

AnonymousJuly 24, 2014 at 4:41 PM
I better get a big raise or a big severance check.
ReplyDelete
Replies
AnonymousJuly 25, 2014 at 10:04 PM
Spoken like a Gentiva higher up.
ReplyDelete
Replies

Add comment